With its central position in neuronal and lysosomal homeostasis, restoration of ATP13A2 function or modulation of ATP13A2-related pathways is a therapeutic potential to reduce α-synuclein burden, mitigate neuroinflammation, and sustain dopaminergic neuron survival in PD. Here, SNCA is linked to Parkinson disease.